Earnings History Data for Pardes Biosciences (PRDS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Pardes Biosciences
Pardes Biosciences Inc. is a clinical-stage biopharmaceutical company. It discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company's lead product candidate includes PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences Inc., formerly known as FS Development Corp. II, is based in SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-05-2023 | AH | 4:00 PM ET (May 5) |
PRDS | Pardes Biosciences | 117.00 | -0.30 | -0.39 | 0.00 | Pardes Biosciences GAAP EPS of -$0.30 beats by $0.11 [5/5/2023 4:33 PM] |
1.92 | 0.02 (1.05%) |
1.84 | -0.06 (-3.08%) |
0.75 - 6.98 | 185,045 | 160,000 | 153 | |
|
|
||||||||||||||||||
| 14-03-2023 | AH | PRDS | Pardes Biosciences | 81.00 | -0.41 | -0.58 | 0.00 | Pardes Biosciences GAAP EPS of -$0.41 beats by $0.09 [3/14/2023 4:56 PM] |
1.38 | 0.08 (6.15%) |
0.0 | 0.0 (0.00%) |
0.75 - 8.75 | 176,379 | 110,000 | 0 | ||
| 07-11-2022 | AH | PRDS | Pardes Biosciences | 78.00 | -0.40 | -0.49 | 0.00 | Pardes Biosciences GAAP EPS of -$0.40 beats by $0.08 [11/7/2022 5:18 PM] |
1.09 | -0.05 (-4.39%) |
0.0 | 0.0 (0.00%) |
1.01 - 17.76 | 89,303 | 230,000 | 0 | ||
| 15-08-2022 | PM | PRDS | Pardes Biosciences | 185.00 | -0.48 | -0.39 | 0.00 | Pardes Biosciences GAAP EPS of -$0.48 [8/15/2022 8:37 AM] |
2.85 | -0.17 (-5.79%) |
0.0 | 0.0 (0.00%) |
2.60 - 17.76 | 74,776 | 120,000 | 0 | ||